Thirty Madison key facts
as of Oct 2026- Operator of a human-first healthcare company intended to support the unique needs of the community with personalized treatments and care.
- Thirty Madison is valued at approximately $500.0M as of Oct 2026, set at a merger or acquisition, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $248.9M across 3 recorded rounds; the latest was Later Stage VC ($112.0M) in Mar 2022.
- Notable investors include Alumni Ventures, Gaingels, Calm Ventures, Greycroft, Evolution VC Partners — 40 tracked in total.
- Thirty Madison has filed 3 Form Ds with the SEC since 2017, most recently Mar 2022 ($112.0M sold to 83 investors).
- Status: Privately Held (backing).
Valued at $500.0M at a merger or acquisition, Aug 2025. Nothing has traded since.
- ·The complete investor list: 40 names
- ·Watch Thirty Madison: the Monday email on marks, rounds and moves
Thirty Madison funding rounds
3 roundsWho backs Thirty Madison
40+Thirty Madison valuation
Thirty Madison was valued at $500 million at a merger or acquisition in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Thirty Madison raised?
Thirty Madison has raised $249 million across 3 recorded rounds since 2017. The largest was a $2.7 million seed round in May 2017; the most recent was an $112 million later-stage round in Mar 2022.
Thirty Madison has filed 3 Form Ds with the SEC since 2017, most recently in Mar 2022 ($112 million sold to 83 investors).
Thirty Madison investors
40 investors are on record for Thirty Madison, including Alumni Ventures, Gaingels, Calm Ventures and Greycroft. By type, the record holds 15 venture capital firms and 2 family offices. The later-stage round in Mar 2022 drew 83 investors.
About Thirty Madison
Operator of a human-first healthcare company intended to support the unique needs of the community with personalized treatments and care. The company builds condition-specific brands that provide end-to-end care for hair loss, a cure for migraine, a treatment for allergies, and a facet for skin conditions, enabling patients to get specialized healthcare brands that create exceptional outcomes for all.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2016
- Employees
- 700
- Website
- thirtymadison.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.